Chimeric Therapeutics Competitors and Similar CompaniesClear all
Chimeric Therapeutics's competitors and similar companies include Spur Therapeutics.
 Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. | ||
Founding Date | Founding Date 2020 | Founding Date 2015 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Carlton, AU HQ | Locations Stevenage, GB HQ Boston, US New York, US |
Employees | Employees N/A | Employees 122 |
Financial | ||
Revenue (est.) | Revenue (est.) $4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $847k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $11.7m (FY, 2025) | Gross profit $8.9m (FY, 2022) |
Net income | Net income ($10.4m) (FY, 2025) | Net income ($89m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Spur Therapeutics
HQ
Stevenage, GB
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
View company